A randomized, double-blind, active-and placebo-controlled study of the analgesic efficacy and safety of repeated dosing of DIC075V [diclofenac] relative to parenteral ketorolac and placebo in patients with acute post-operative pain after elective orthopedic surgery

Trial Profile

A randomized, double-blind, active-and placebo-controlled study of the analgesic efficacy and safety of repeated dosing of DIC075V [diclofenac] relative to parenteral ketorolac and placebo in patients with acute post-operative pain after elective orthopedic surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Dec 2014

At a glance

  • Drugs Diclofenac (Primary) ; Ketorolac
  • Indications Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Javelin Pharmaceuticals
  • Most Recent Events

    • 20 Oct 2010 Secondary endpoints presented at the 2010 Annual Meeting of the American Society of Anesthesiologists.
    • 10 Dec 2008 Results were reported in a Javelin Pharmaceuticals media release and complete analysis of data from this trial will be submitted for presentation at a medical meeting in 2009.
    • 10 Dec 2008 Primary endpoint 'Pain intensity' has been met according to a Javelin Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top